As of November 6, 2026, Tenaya Therapeutics, Inc. is a publicly traded company (Nasdaq: TNYA). The largest holder reporting an active stake on Schedule 13D is The Column Group III, LP, at 23.1%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Integrated Core Strategies (US) LLC (5.2%) (Schedule 13D/A, February 26, 2026).
Is this your company?
About to sign with, pay or invest in Tenaya Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Tenaya Therapeutics, Inc. a real, registered company?
- Tenaya Therapeutics, Inc. files with the SEC under CIK 1858848 (its SEC filings).
- Its shares are listed under the ticker TNYA on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in South San Francisco, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Tenaya Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Eric Hyllengren, Chief Financial Officer (Form 8-K filed 2026-06-29). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Integrated Core Strategies (US) LLC (filed 2026-08-24).
Who are Tenaya Therapeutics, Inc.'s owners and officers?
Tenaya Therapeutics, Inc.: incorporated in Delaware; business address in South San Francisco, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G, 2026-08-24).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-24 | Integrated Core Strategies (US) LLC | 5.2% |
| Schedule 13D/A, 2026-02-26 | The Column Group Iii, LP | 23.1% |
| Schedule 13D/A, 2026-02-12 | The Column Group Iii, LP | 25.4% |
| Schedule 13D/A, 2025-12-17 | The Column Group Iii, LP | 23.1% |
| Schedule 13G/A, 2025-08-14 | Woodline Partners LP | 4.99% |
| Schedule 13G/A, 2025-07-31 | Empery Asset Management, LP | 4.99% |
| Schedule 13G/A, 2025-07-16 | Blackrock, Inc. | 1.7% |
Questions about who owns Tenaya Therapeutics, Inc.
Who owns Tenaya Therapeutics, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Tenaya Therapeutics, Inc.: The Column Group Iii, LP (23.1%, Schedule 13D/A, filed 2026-02-26) and Integrated Core Strategies (US) LLC (5.2%, Schedule 13G, filed 2026-08-24).
Who are the largest shareholders of Tenaya Therapeutics, Inc.?
By the share each holder's latest filing reports, the largest holders of Tenaya Therapeutics, Inc. on this page are The Column Group Iii, LP (23.1%) and Integrated Core Strategies (US) LLC (5.2%).
When did The Column Group Iii, LP buy into Tenaya Therapeutics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from The Column Group Iii, LP on this page is the Schedule 13D/A, filed 2025-12-17, reporting 23.1%; its latest, Schedule 13D/A filed 2026-02-26, reports 23.1%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Tenaya Therapeutics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Tenaya Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tenaya Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-29 | Eric Hyllengren | Chief Financial Officer | appointed |
Which insiders own Tenaya Therapeutics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 49,313,559 shares (21.6% of shares outstanding), held indirectly (the form names the holder only in its footnotes) (Form 4, 2025-03-07).
- , the chief executive and a director: 539,782 shares (0.24% of shares outstanding) (Form 4, 2026-09-11).
- , the chief medical officer: 263,073 shares (0.12% of shares outstanding) (Form 4, 2026-09-11).
- , the senior vice president and finance: 118,267 shares (0.05% of shares outstanding) (Form 4, 2026-05-19).
- , the senior vice president and accounting: 60,983 shares (0.03% of shares outstanding) (Form 4, 2024-11-18).
Shares outstanding: 227,928,240 as of 2026-10-29, from the company's latest SEC cover page.
How much has Tenaya Therapeutics, Inc. raised?
No fundraising or offering filing from Tenaya Therapeutics, Inc. is on file with us.
Keep reading
More on Tenaya Therapeutics, Inc. and the records around it.
Tenaya Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Leadership changes Jun 2026
Companies that share a holder
- Woodline Partners LP also filed stake reports on 19 other companies: Biohaven Ltd. (Aug 2026), Black Rock Coffee Bar, Inc. (Aug 2026), CalciMedica, Inc. (Aug 2026)
- Empery Asset Management, LP also filed stake reports on 21 other companies: Dyadic International Inc. (Oct 2026), Femasys Inc. (Oct 2026), Clene Inc. (Oct 2026)
- Integrated Core Strategies (US) LLC also filed stake reports on 63 other companies: SkinHealth Systems Inc. (Nov 2026), Infinite Eagle Acquisition Corp. (Nov 2026), Longeveron Inc. (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/tenaya-therapeutics